These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31066103)

  • 1. Targeting HIV-TB coinfection by developing novel piperidin-4-substituted imines: Design, synthesis, in vitro and in silico studies.
    Kumar A; Revathi R; Sriram D; Curreli F; Debnath AK; Pai KS; Kini SG
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800358. PubMed ID: 31066103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents.
    Revathi R; Venkatesha Perumal R; Pai KS; Arunkumar G; Sriram D; Kini SG
    Drug Des Devel Ther; 2015; 9():3779-87. PubMed ID: 26229439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non Nucleoside Reverse Transcriptase Inhibitors, Molecular Docking Studies and Antitubercular Activity of Thiazolidin-4-one Derivatives.
    Chitre TS; Patil SM; Sujalegaonkar AG; Asgaonkar KD; Khedkar VM; Garud DR; Jha PC; Gaikwad SY; Kulkarni SS; Choudhari A; Sarkar D
    Curr Comput Aided Drug Des; 2019; 15(5):433-444. PubMed ID: 30574853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
    Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
    Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of phosphino palladium(II) and platinum(II) complexes against HIV-1 and Mycobacterium tuberculosis.
    Gama NH; Elkhadir AY; Gordhan BG; Kana BD; Darkwa J; Meyer D
    Biometals; 2016 Aug; 29(4):637-50. PubMed ID: 27246555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.
    Tiwari AP; Sridhar B; Boshoff HI; Arora K; Gautham Shenoy G; Vandana KE; Varadaraj Bhat G
    Mol Divers; 2020 Nov; 24(4):1265-1279. PubMed ID: 31506871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs.
    Sriram D; Yogeeswari P; Gopal G
    Eur J Med Chem; 2005 Dec; 40(12):1373-6. PubMed ID: 16129516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, Pharmacological Evaluation, In silico Modeling, Prediction of Toxicity and Metabolism Studies of Novel 1-(substituted)-2-methyl- 3-(4-oxo-2-phenyl quinazolin-3(4H)-yl)isothioureas.
    Sulthana MT; Alagarsamy V; Chitra K
    Med Chem; 2021; 17(4):352-368. PubMed ID: 32807063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MoS
    Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
    ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
    Nayak N; Ramprasad J; Dalimba U
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, anti-HIV and antitubercular activities of nelfinavir diester derivatives.
    Sriram D; Yogeeswari P; Dinakaran M; Sowmya M
    Biomed Pharmacother; 2008 Jan; 62(1):1-5. PubMed ID: 17890044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
    Venugopala KN; Deb PK; Pillay M; Chopra D; Chandrashekharappa S; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Kandeel M; Venugopala R; Mohanlall V
    Curr Top Med Chem; 2021; 21(4):295-306. PubMed ID: 33138763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
    Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM
    Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
    Kumar G; Krishna VS; Sriram D; Jachak SM
    Eur J Med Chem; 2018 Aug; 156():871-884. PubMed ID: 30056283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
    Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New azaaurone derivatives as potential multitarget agents in HIV-TB coinfection.
    Leite DI; Campaniço A; Costa PAG; Correa IA; da Costa LJ; Bastos MM; Moreira R; Lopes F; Jordaan A; Warner DF; Boechat N
    Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300560. PubMed ID: 38032154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.